Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

Delayed Quote. Delayed  - 05/24 09:59:59 pm
7.97 USD   -1.36%
05/24 ARIAD PHARMACEU : Company Update Ariad Pharmaceuticals, Inc. Announc..
05/24 ARIAD PHARMACEU : Announces Appointment of Jennifer L. Herron as Chi..
05/19 ARIAD PHARMACEU : Announces Pricing and Reimbursement for Iclusig in..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ARIAD PHARMACEUTICALS, INC
06/04/16 | 03:00pm American society of clinical oncology meeting - abstract no: 9060
06/04/16 | 03:00pm American society of clinical oncology meeting - abstract no: 9057
06/06/16 | 06:30pm American society of clinical oncology meeting - abstract no: 053
06/06/16 | 06:30pm American society of clinical oncology meeting - abstract no: 013
Past events on ARIAD PHARMACEUTICALS, INC
05/10/16 | 02:30pm Q1 2016 Earnings Call
05/10/16 Q1 2016 Earnings Release
05/09/16 | 02:30pm Acquisition of ARIAD's European Operations by Incyte Corporation Call
03/17/16 | 01:00pm Barclays Global Health Care Conference
Upcoming sector events for ARIAD PHARMACEUTICALS, INC
05/25/16 ALKERMES PLC : Annual General Meeting
05/25/16 | 04:30pm CELGENE CORPORATION : UBS Global Health Care Conference
05/27/16 INCYTE CORPORATION : Annual General Meeting
06/02/16 | 10:00pm CELGENE CORPORATION : Bernstein Strategic Decisions Conference
Annual publications
Previous yearNext Year
Annual results2012201320142015 (e)2016 (e)
Sales
Million $
Released
Forecast
Spread
0,56
0,92
-39%
45,6
43,6
4,4%
105
77,8
36%

123

217
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-197
-199
1,0%
-269
-281
4,0%
-151
-166
8,9%
-205
-208
1,8%

-105
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-205
-204
-0,54%
-274
-286
4,2%
-160
-183
12%
-217
-223
2,4%

-96,5
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-221

-274







Net income
Million $
Released
Forecast
Spread
-221
-218
-1,5%
-274
-286
4,1%
-163
-183
11%

-236

-108
EPS
 $
Released
Forecast
Spread
-1,34
-1,32
-1,3%
-1,49
-1,56
4,3%
-0,87
-0,97
9,9%
-1,23
-1,26
2,6%

-0,56
Announcement Date02/25/201302/25/201402/19/201511/30/-0001

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ3
2015
Q4
2015
Q1
2016
Q2
2016 (e)
Q3
2016 (e)
Sales
Million $
Released
Forecast
Spread
29,1
46,1
-37%

41,4
35,6
43,3
-18%

58,0

44,6
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-53,1
-56,3
5,7%

-63,2






Operating profit (EBIT)
Million $
Released
Forecast
Spread
-56,4
-51,0
-10%

-58,6
-44,9
-43,9
-2,3%

-15,4

-31,1
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
-55,5
-45,9
-21%

-65,1
-53,8
-45,4
-18%

-26,4

-34,8
EPS
 $
Released
Forecast
Spread
-0,29
-0,25
-16%

-0,34
-0,28
-0,24
-17%

-0,14

-0,18
Announcement Date11/03/201505/10/2016

© 2016 Thomson Reuters
© 2016 Factset
Advertisement
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise